SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-10-21 11:18
Tx date 2025-10-16 		$MVI
Monitor Ventures Inc. (formerly, American Vanadium Corp.) 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$49,875
+665,000 vol
$0.075 each 		665,000
Filed 2025-10-20 16:57
Tx date 2025-10-16 		$MVI
Monitor Ventures Inc. (formerly, American Vanadium Corp.) 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+665,000 vol
Filed 2025-10-20 16:57
Tx date 2025-10-16 		$MVI
Monitor Ventures Inc. (formerly, American Vanadium Corp.) 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+665,000 vol 		665,000
Filed 2024-04-08 12:44
Tx date 2023-11-29 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$-131,600
-40,000 vol
$3.29 each 		0
Filed 2024-04-08 12:42
Tx date 2021-11-29 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+40,000 vol 		40,000
Filed 2024-04-08 12:30
Tx date 2021-11-29 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+40,000 vol
Filed 2024-04-08 12:20
Tx date 2024-03-13 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-100,000
-100,000 vol
$1.00 each 		376,000
Filed 2024-03-18 13:11
Tx date 2024-03-13 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$100,000
+100,000 vol
$1.00 each
Filed 2021-11-29 13:16
Tx date 2021-11-29 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+80,000 vol
Filed 2024-03-29 18:13
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$30,000
+10,000 vol
$3.00 each 		90,000
Filed 2024-03-29 18:11
Tx date 2024-03-28 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$47,000
+20,000 vol
$2.35 each 		1,407,500
Filed 2024-03-18 13:11
Tx date 2024-03-13 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$100,000
+100,000 vol
$1.00 each 		1,387,500
Filed 2024-03-18 13:11
Tx date 2024-03-13 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$100,000
+100,000 vol
$1.00 each 		576,000
Filed 2023-11-27 12:01
Tx date 2023-11-27 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$-1,920
-1,000 vol
$1.92 each 		1,287,500
Filed 2023-10-02 17:36
Tx date 2023-09-27 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,000
-1,000 vol
$2.00 each 		1,288,500
Filed 2023-09-01 15:02
Tx date 2023-09-01 		$MVI
Monitor Ventures Inc. (formerly, American Vanadium Corp.) 		Radvak, William Joseph
4 - Director of Issuer
Holder: Westcorp Management (Indirect Ownership)
Common Shares
99 - Correction of information
-10,000 vol 		0
Filed 2023-09-01 15:01
Tx date 2023-09-01 		$MVI
Monitor Ventures Inc. (formerly, American Vanadium Corp.) 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-28,272 vol 		0
Filed 2023-05-24 00:26
Tx date 2023-05-23 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$80,500
+50,000 vol
$1.61 each 		476,000
Filed 2023-02-28 10:49
Tx date 2023-02-28 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,400
+60,000 vol
$1.94 each 		426,000
Filed 2023-01-16 16:32
Tx date 2023-01-10 		$NGEN
NervGen Pharma Corp. 		Radvak, William Joseph
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-312,000
-150,000 vol
$2.08 each 		366,000